Validation of T1w‐based segmentations of white matter hyperintensity volumes in large‐scale datasets of aging

Introduction Fluid‐attenuated Inversion Recovery (FLAIR) and dual T2w and proton density (PD) magnetic resonance images (MRIs) are considered to be the optimum sequences for detecting white matter hyperintensities (WMHs) in aging and Alzheimer's disease populations. However, many existing large...

Full description

Saved in:
Bibliographic Details
Published inHuman brain mapping Vol. 39; no. 3; pp. 1093 - 1107
Main Authors Dadar, Mahsa, Maranzano, Josefina, Ducharme, Simon, Carmichael, Owen T., Decarli, Charles, Collins, D. Louis
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.03.2018
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction Fluid‐attenuated Inversion Recovery (FLAIR) and dual T2w and proton density (PD) magnetic resonance images (MRIs) are considered to be the optimum sequences for detecting white matter hyperintensities (WMHs) in aging and Alzheimer's disease populations. However, many existing large multisite studies forgo their acquisition in favor of other MRI sequences due to economic and time constraints. Methods In this article, we have investigated whether FLAIR and T2w/PD sequences are necessary to detect WMHs in Alzheimer's and aging studies, compared to using only T1w images. Using a previously validated automated tool based on a Random Forests classifier, WMHs were segmented for the baseline visits of subjects from ADC, ADNI1, and ADNI2/GO studies with and without T2w/PD and FLAIR information. The obtained WMH loads (WMHLs) in different lobes were then correlated with manually segmented WMHLs, each other, age, cognitive, and clinical measures to assess the strength of the correlations with and without using T2w/PD and FLAIR information. Results The WMHLs obtained from T1w‐Only segmentations correlated with the manual WMHLs (ADNI1: r = .743, p < .001, ADNI2/GO: r = .904, p < .001), segmentations obtained from T1w + T2w + PD for ADNI1 (r = .888, p < .001) and T1w + FLAIR for ADNI2/GO (r = .969, p < .001), age (ADNI1: r = .391, p < .001, ADNI2/GO: r = .466, p < .001), and ADAS13 (ADNI1: r = .227, p < .001, ADNI2/GO: r = .190, p < 0.001), and NPI (ADNI1: r = .290, p < .001, ADNI2/GO: r = 0.144, p < .001), controlling for age. Conclusion Our results suggest that while T2w/PD and FLAIR provide more accurate estimates of the true WMHLs, T1w‐Only segmentations can still provide estimates that hold strong correlations with the actual WMHLs, age, and performance on various cognitive/clinical scales, giving added value to datasets where T2w/PD or FLAIR are not available.
Bibliography:Funding information
http://adni.loni.usc.edu/wp-ontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
Part of the data used in the preparation of this article was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database
As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at
Famille Louise & André Charron; Canadian Institutes of Health Research, Grant/Award Number: MOP‐111169; les Fonds de Research Santé Québec Pfizer Innovation Fund; NSERC CREATE Grant, Grant/Award Number: 4140438 ‐ 2012; Levesque Foundation; Government of Canada; Canada Fund for Innovation; NIH, Grant/Award Numbers: P30AG010129, K01 AG030514; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health), Grant/Award Number: U01 AG024904; DOD ADNI (Department of Defense), Grant/Award Number: W81XWH‐12‐2‐0012
adni.loni.usc.edu
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Funding information Famille Louise & André Charron; Canadian Institutes of Health Research, Grant/Award Number: MOP‐111169; les Fonds de Research Santé Québec Pfizer Innovation Fund; NSERC CREATE Grant, Grant/Award Number: 4140438 ‐ 2012; Levesque Foundation; Government of Canada; Canada Fund for Innovation; NIH, Grant/Award Numbers: P30AG010129, K01 AG030514; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health), Grant/Award Number: U01 AG024904; DOD ADNI (Department of Defense), Grant/Award Number: W81XWH‐12‐2‐0012
Part of the data used in the preparation of this article was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-ontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
ISSN:1065-9471
1097-0193
1097-0193
DOI:10.1002/hbm.23894